Daily news email for August 15, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
ZZ Biotech Initiates Phase 1 Study with 3K3A-APC for the Treatment of Acute Ischemic Stroke

AiCuris Promising Drugs Against Herpes Simplex (AIC316) and Human Cytomegalovirus (Letermovir, ...

CEVEC Licenses its Proprietary Human Cell Lines to Paragon Bioservices, Inc.

Cambridge Research Biochemicals Signs Deal with LI-COR Biosciences for Infrared Dye Labelled ...

2. Laupheimer Zelltage Attracts Top Scientists to Discuss Recent Advances in Biomanufacturing

BioSpace
Eisai Inc. CEO Sees "Huge" Medical Need for New Diet Drug

Nicholas J. Valeriani, 34-Year Johnson & Johnson Veteran, Appointed Chief Executive of West Health

Obese Women More Likely to Have Large Babies, Kaiser Permanente Study

Brain Areas Cooperate to Keep Us "Proper," McGill University Study

Why Do Women Get More Migraines than Men Harvard Medical School Study

BioSpace - Breaking News
Burnet Institute Release: Major Breakthrough in Hepatitis C Vaccine Development

Cortex Pharmaceuticals, Inc. and Consummate Merger

TONIX Pharmaceuticals, Inc. Reports That Sublingual Formulation of Fibromyalgia Drug Reduces Production of a Psychoactive Metabolite, Improving Suitability for Long-Term, Chronic Treatment

Soricimed Biopharma, Inc. Announces First Patient Treated in Phase I Clinical Trial of New Cancer Drug, SOR-C13

Proteonomix, Inc. (PROT) Receives FDA Permission to Initiate Company-Sponsored Phase 1 Clinical Trial With UMK-121 in Patients with End-Stage Liver Disease

Biotech News - Business Wire
Thiel Foundation's Breakout Labs Announces Newest Grants at the Intersection of Biology and Advanced Technologies

Verdezyne Announces Issuance of US Patent on Method for Producing Bio-Based Adipic Acid

ImmunoCellular Therapeutics Reports Second Quarter Results

Sprained Ankle Treatment in Thailand by Vejthani Hospital

HEI, Inc. Announces Second Quarter 2012 Results

Biotech News - PR Newswire
Delcath Submits New Drug Application For Proprietary Chemosaturation System To The U.S. Food And Drug Administration

Renaissance Pharma Acquires Cold Sore Treatment Denavir®

University of Miami study finds RBAC to possess promising immunomodulating effects with respect to natural killer cell and cytokine activity

Life Sciences Venture Capital Funding Shrinks for Fourth Straight Quarter According to the MoneyTree Report

Organovo Reports Q2 2012 Financial Results, Provides Business Update

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
Innovation Bank Proposed

China Invests in U.K. Diagnostics Startup

Alzheimer's Drug Bapineuzumab Fails in Second Trial

Nanobiotix teams up with PharmaEngine in Nanomedicine Deal

Pharma Heads Back to School

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Research and Markets: Leiomyosarcoma Global Clinical Trials Review, H2, 2012

Research and Markets: Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2012

Radiology Quality Institute eBook Defines Quality Standards in Radiology

Research and Markets: Sleep Disorders Global Clinical Trials Review, H1, 2012

Research and Markets: Fabry Disease Global Clinical Trials Review, H1, 2012

Clinical Trials - PR Newswire
Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer

Sound Interventions Updates Results From "SOUND-ITV" Trial Of Ultrasound-based Renal Denervation For Resistant Hypertension

Fetal Surveillance Company, PeriGen, Inc., to Collaborate with National Institute of Child Health and Human Development to Research Fetal Heart Rate Patterns During Labor

First Patient Procedure Using the ClearPoint® Neuro Intervention System Performed at Memorial Sloan Kettering Cancer Center in Pediatric Brain Cancer Clinical Trial

Over-the-Counter Prostate Treatment PHC® Awarded U.S. Patent

CNN Top Stories
Pinterest releases iPad, Android apps

Scary cigarette labels -- will they work

Opinion: Let young immigrants stay

Pinterest releases new apps

Opinion: Work with Russia, Iran on Syria

Contract Pharma
Morphotek Opens Manufacturing Plant

Regulus, AstraZeneca To Develop microRNA

EMD Millipore, Plasticell in Licensing Pact

Cambrex Wins Supply Agreement

Quintiles Acquires Expression Analysis

FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

FDA Drug Safety Communication: Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

FDA News - Business Wire
CryoPen Unveils Revolutionary New Cervical Cancer Treatment

United Health Products Epic Wound Care Inc. Receives 510K approval on its Hemostyp Trauma Gauze

Vasomedical Announces 48.7% Increase in Revenue for the Second Quarter 2012

Proteonomix Receives FDA Permission to Initiate Company-Sponsored Phase 1 Clinical Trial with UMK-121 in Patients with End-Stage Liver Disease

Digital Marketing Teams Solidify Their Staffing at Top 10 Pharma Companies

FDA Press Releases
FDA approves vaccines for the 2012-2013 influenza season

FDA approves vaccine formulation for the 2012-2013 influenza season

FDA approves Lucentis to treat diabetic macular edema

FDA approves Marqibo to treat rare type of leukemia

FDA revises safety information and limits use of Stryker Wingspan brain stent system

FDA Vaccines, Blood and Biologics - What's New
Black Widow Spider Antivenin (Latrodectus mactans)(Equine) Packaged Lot 0585Z: Information about Expiration Date and Use

Cord Blood Banking - Information for Consumers

Package Insert - Twinrix

Direct Recall Classification Program

Draft Guidance for Industry: Amendment to Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products

FierceBiotech
R&D experts applaud new initiative to validate biomedical studies

Open-innovation projects turn old R&D wisdom 'on its head'

Eisai chief outlines Belviq sales effort, deal strategy

Relypsa completes $80M round as it preps pivotal heart study

Struggling Tengion threatens bankruptcy as it scrambles for cash

FierceBiotech IT
Big data analytics bolsters hunt for elusive Huntington's drugs

Quintiles gains genomic, bioinformatics know-how in buyout

U.K. scientists tap into ehealth research with Centers of Excellence

Merck to draw on social network for psoriasis patients

Schadt reflects on first year at $100M genomics center

FierceBiotech Research
Prosthetic retina restores partial sight to blind mice

Gene offers tantalizing leukemia target

Newly discovered, overexpressed gene offers tantalizing leukemia target

University of Cambridge debuts latest stem cell research institute

Nanomaterial propels self-repair for damaged hearts

FiercePharma
FTC gives blessing to drug shortage effort

Watson sues FDA for delay of generic Actos launch

Lawmakers pressure Gilead on Quad price ahead of approval

New pharma trial: Pfizer, GSK, J&J test 1-page drug information sheets

GSK sells off more low-margin brands as it focuses on HGS

FiercePharma Manufacturing
FDA turns to Merck on Sanofi cancer drug shortage

GPhA drug shortage plan passes FTC smell test

Internet drug dealer gets 10 years but feds want his Chinese boss

Acino opens German plant to make Bayer birth control patches

FDA asks Merck to make up for Sanofi cancer drug shortage

FierceVaccines
FDA approves 6 flu vaccines

PharmAthene's anthrax vax put on hold as shares plummet

Researchers discover malaria target

Immatics' kidney cancer vaccine extends lives in trials

Sanofi readies defense as judge rules antitrust lawsuit can proceed

Health News - BizJournals.com
North Highland names Martinez CMO

Announcing: The Business Journal's 2012 Diverse Business Leaders

Science Center to construct building near Penn

Vermillion improves on 2Q loss

Independence Blue Cross adds 3 health plans

Health News - CNBC
Medicis' skin drug gets generic threat from Actavis Mid Atlantic

J&J removing harsh chemicals from products by 2015

Private equity firm to buy Physicians Formula

Australia court deals blow to tobacco firms, endorses tough marketing laws

Australian court deals blow to global tobacco giants

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
AstraZeneca Partners on miRNA Inhibitors

Firms Flock to Epic's CTC Platform

Elan to Cut Loose its Discovery Subsidiary

Some Better News for Avastin

Amgen Anticancer Antibody Bites the Dust

Marketwire - Pharma and Biotech
Innovotech Reports Second Quarter 2012 Financial Results

Sunshine Biopharma Announces Submission of an Adva-27a Manuscript for Publication in a Peer-Reviewed Scientific Journal

Ingen Technologies Inc. Signs LOI to Acquire SomaLife Consulting LLC

EnWave Signs Research & Development Agreement With an Option to License With Sun-Maid Growers of California

Immunovative, Inc. Announces the Appointment of Dr. Laurence Terrisse-Rulleau to Business Advisory Board

MassBio News
GNS Healthcare And CHDI Foundation Collaborate To Build Computer Model Of Huntington's Disease

Stericycle Hosting Four FREE DOT Hazmat Trainings for MassBio Members Via Webex

Stericycle Adds SteriSafe for MassBio Members

FierceBiotech will announce 2012 "Fierce 15" at BioPharm America in September

State, Local and Industry Officials Join KeraFAST to Open New Headquarters in Boston, MA

Medical Pharma - PR Newswire
ConsultantLive Features Special Photoclinic Content

Net Medical Xpress Announces Q2'2012 and Six Months 2012 Results

Medical Marijuana, Inc. Reports Second Quarter 2012 Revenue and Income Quarter Over Quarter Increase Of Over 1200 Percent From Same Period Last Year

OnCure Holdings, Inc. Announces Second Quarter 2012 Conference Call

DATATRAK International, Inc. Announces Second Quarter 2012 Results

National Center for Biotechnology Information
GenBank Submission Tools Announcements

GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

Nature Biotechnology
Reply to In support of the European Union biosimilar framework

In support of the European Union biosimilar framework

It's the problem, stupid!

Adult stem cell therapies walk the line

Biotech weathers 2Q12 slump

New York Times- Biotechnology
Novel Blood Treatment Lures Athletes in Pain to Germany

Athletes With Chronic Pain Turn to Novel Blood Treatment

Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

Craig Venter’s Bugs Might Save the World

Study Backs Continuous Prostate Cancer Treatment

New York Times- Pharmaceuticals
Pfizer Animal Health Unit Files for I.P.O.

Beware the Nocebo Effect

Amgen, Citing Weak Results, Halts Study of Pancreatic Cancer Drug

Bristol Executive Is Accused of Inside Deals

Prescription Skin Creams Jump in Price

OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

Outsourcing-Pharma
Wockhardt targets CMO space for diversification

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India

Pharma News - Business Wire
Global Green, Inc. Announces Appointment of Konky Sotomayor, DVM as Chief Scientist

HHS partners with pharmacies to educate Medicare beneficiaries about new health benefits

Research and Markets: Commercializing Breast Cancer Drugs: The 2012 Faster Route to Consider Your Options and Position of Others

IMS Health Acquires TTC, Strengthening Pharma R&D Services Capabilities

Walgreens and HHS Work Together to Educate Medicare Beneficiaries about New Health Benefits

Pharma News - PharmiWeb
North Highland Appoints Dr. Ricardo Martinez as Chief Medical Officer

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Wound Drainage Products

Charter Fitness to Open 14,000 Square-Foot Flagship Facility in Crystal Lake, IL

Newly Established Bestnet A/S Partnership Will Revolutionize Living Conditions for the World's Poorest Populations

Mark Farrah Associates Finds First Quarter 2012 Results Mixed for Top Health Plans

Pharma News - PR Newswire
Kaiser Permanente Appoints Alexandra Morehouse as Vice President of Advertising and Brand Management

Carl Icahn Wins Seat On Forest Labs Board

Watson Sues FDA Regarding Delay of Generic Actos® Approval

National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges Nashville Parents to Vaccinate Preteens and Teens

Elsevier Acquires Atira, a Provider of Research Management Solutions

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Romer Labs Launches New Website

SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

PRWeb - Biotechnology
BioProcess International Announces Finalists for the 2012 BioProcess...

Nobel Laureate Sir Harry Kroto to Deliver the Pittcon 2013 Wallace H....

National PTSD Consortium To Improve Diagnosis, Treatment

Fat Grafting, Stem Cell Combination Replaces Implants

Air Innovations Expands Psychrometric Facility

PRWeb - Pharmaceuticals
Stainless Motors, Inc. Announces Release of Sanifan Technology

LiquidCMO Formulation Gives Dramatic Results For Fibromyalgia Patients

Redflag on Biometric Iris Scanning

Ashworth College Launches Certified Pharmacy Technician Career...

Stryker Hip Recall News: First Stryker Hip Recall Lawsuit Filed

Scientific American
U.S. Swine Flu Outbreak Spikes

Climate Change Shaped Ancient Mummification Practices

Common Lab Dye Found to Interrupt Formation of Huntington's Disease Proteins

Prosthetic Retina Helps to Restore Sight in Mice

Exxon Valdez Laid to Rest

Sports - ESPN Basketball
Sources: Muhammad to sit out UCLA China trip

Lumpkins to return to American's hoops team

Nova coach with resume discrepancies resigns

Nova asst. resigns due to resume inaccuracies

Despite claims, no record of Nova asst. playing

Sports News - ESPN
Alabama reports 27 secondary rules violations

Ex-Miami DB Armstrong enrolls at NAIA school

OL Thomas, S Johnson leave Red Raiders

Sources: 2-horse race to host Champions Bowl

Miles quiet about possible return of Mathieu

Xconomy Life Sciences
Bill Gates Looks to Foster Toilet Innovations for the 21st Century

Remove the Cap on Social Security

Kineta Pulls in $5.8M for Autoimmune Drug

Elcelyx Therapeutics Raises $4M to Treat Obesity and Diabetes

Relypsa Gets Another $50M for Drug to Fight Excess Potassium

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)